HRP20100638T2 - Viralni vektori i njihova uporaba - Google Patents

Viralni vektori i njihova uporaba Download PDF

Info

Publication number
HRP20100638T2
HRP20100638T2 HR20100638T HRP20100638T HRP20100638T2 HR P20100638 T2 HRP20100638 T2 HR P20100638T2 HR 20100638 T HR20100638 T HR 20100638T HR P20100638 T HRP20100638 T HR P20100638T HR P20100638 T2 HRP20100638 T2 HR P20100638T2
Authority
HR
Croatia
Prior art keywords
viral vector
interest
vector according
nucleotide sequence
polynucleotide containing
Prior art date
Application number
HR20100638T
Other languages
English (en)
Croatian (hr)
Inventor
Smerdou Picazo Cristian
Casales Zoco Erkuden
Roberto Rodr�guez Madoz Juan
Razqu�n Erro Nerea
Cuevas Labrador Yolanda
Ruiz Guill�n Marta
Prieto Valtuena Jes�s
Original Assignee
Proyecto De Biomedicina Cima
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES200700882A external-priority patent/ES2304880B1/es
Application filed by Proyecto De Biomedicina Cima filed Critical Proyecto De Biomedicina Cima
Publication of HRP20100638T1 publication Critical patent/HRP20100638T1/xx
Publication of HRP20100638T2 publication Critical patent/HRP20100638T2/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/36011—Togaviridae
    • C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
    • C12N2770/36141—Use of virus, viral particle or viral elements as a vector
    • C12N2770/36143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HR20100638T 2006-11-28 2007-11-28 Viralni vektori i njihova uporaba HRP20100638T2 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200603036 2006-11-28
ES200700882A ES2304880B1 (es) 2007-04-03 2007-04-03 Uso de un vector viral mutado para la generacion in vitro de lineas celulares estables.
PCT/ES2007/000688 WO2008065225A2 (es) 2006-11-28 2007-11-28 Vector viral y sus aplicaciones

Publications (2)

Publication Number Publication Date
HRP20100638T1 HRP20100638T1 (en) 2010-12-31
HRP20100638T2 true HRP20100638T2 (hr) 2011-03-31

Family

ID=39468303

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20100638T HRP20100638T2 (hr) 2006-11-28 2007-11-28 Viralni vektori i njihova uporaba

Country Status (18)

Country Link
US (1) US20100055736A1 (de)
EP (1) EP2097533B9 (de)
JP (1) JP2010510790A (de)
AT (1) ATE478959T1 (de)
AU (1) AU2007327452B2 (de)
BR (1) BRPI0719572A2 (de)
CA (1) CA2670163A1 (de)
CY (1) CY1111187T1 (de)
DE (1) DE602007008761D1 (de)
DK (1) DK2097533T3 (de)
HR (1) HRP20100638T2 (de)
MX (1) MX2009005572A (de)
PL (1) PL2097533T3 (de)
PT (1) PT2097533E (de)
RS (1) RS51484B (de)
RU (1) RU2009124471A (de)
SI (1) SI2097533T1 (de)
WO (1) WO2008065225A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0913045A2 (pt) * 2008-05-23 2017-05-23 Fit Biotech Oy vetor de expressão codificador de alfa-vírus replicase e uso do mesmo como adjuvante imunológico
WO2011064437A2 (es) 2009-11-26 2011-06-03 Proyecto De Biomedicina Cima, S.L. Vectores virales y procedimientos útiles en la preparación de gdnf
CN102286627B (zh) * 2011-09-08 2014-04-23 北京利德曼生化股份有限公司 一种牛分枝杆菌和人结核分枝杆菌的同时鉴定方法及其试剂盒
ES2523016B1 (es) 2013-05-20 2015-09-09 3P Biopharmaceuticals Vectores alfavirales y líneas celulares para la producción de proteínas recombinantes
EP2878674A1 (de) 2013-11-28 2015-06-03 Fundación Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) Stabile Episomen auf Basis von nichtintegrativen lentiviralen Vektoren
JP6569124B2 (ja) * 2015-11-12 2019-09-04 住友電装株式会社 導電部材製造方法、導電部材及び金型
US12134790B2 (en) 2017-09-27 2024-11-05 Inozyme Pharma, Inc. Methods of improving cardiovascular function and treating cardiovascular disease using a recombinant ectonucleotide pyrophosphatase phosphodiesterase (NPP1)
WO2021252549A1 (en) 2020-06-09 2021-12-16 Inozyme Pharma, Inc. Soluble enpp1 or enpp3 proteins and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9326271D0 (en) 1993-12-23 1994-02-23 Zeneca Ltd Expression of self-processing polyprotein in transgenic plants
US6458560B1 (en) * 1996-04-05 2002-10-01 Chiron Corporation Recombinant alphavirus-based vectors with reduced inhibition of cellular macromolecular synthesis
WO2004046340A2 (en) * 2002-11-14 2004-06-03 Genentech, Inc. Intron fusion construct and method of using for selecting high-expressing production cell lines
ES2292271B1 (es) * 2004-05-20 2009-02-16 Proyecto De Biomedicina Cima, S.L. Un vector hibrido adenovirus-alfavirus para la administracion eficaz y expresion de genes terapeuticos en celulas tumorales.

Also Published As

Publication number Publication date
RS51484B (sr) 2011-04-30
US20100055736A1 (en) 2010-03-04
PT2097533E (pt) 2010-11-29
SI2097533T1 (sl) 2010-11-30
AU2007327452B2 (en) 2012-08-30
WO2008065225A2 (es) 2008-06-05
ATE478959T1 (de) 2010-09-15
DE602007008761D1 (de) 2010-10-07
BRPI0719572A2 (pt) 2013-12-10
CA2670163A1 (en) 2008-06-05
HRP20100638T1 (en) 2010-12-31
RU2009124471A (ru) 2011-01-10
EP2097533B9 (de) 2010-12-22
DK2097533T3 (da) 2010-11-01
EP2097533B1 (de) 2010-08-25
WO2008065225A3 (es) 2008-08-14
EP2097533A2 (de) 2009-09-09
MX2009005572A (es) 2009-07-30
CY1111187T1 (el) 2015-06-11
PL2097533T3 (pl) 2011-02-28
JP2010510790A (ja) 2010-04-08
AU2007327452A1 (en) 2008-06-05

Similar Documents

Publication Publication Date Title
HRP20100638T2 (hr) Viralni vektori i njihova uporaba
US12460229B2 (en) Recombinant arterivirus replicon systems and uses thereof
ES2847698T3 (es) Construcción de ácido nucleico
AU698976B2 (en) Alphavirus expression vector
US11845939B2 (en) Compositions and methods for enhancing gene expression
CN113227122B (zh) 用于生物治疗剂给药的基于甲病毒的复制子
US5739026A (en) DNA expression systems based on alphaviruses
Buchholz et al. In vivo selection of protease cleavage sites from retrovirus display libraries
ES2778905T3 (es) Constructo de ácido nucleico para la expresión de más de un receptor de antígeno quimérico
Baroth et al. Insertion of cellular NEDD8 coding sequences in a pestivirus
WO2000039318A1 (en) Compositions and methods for packaging of alphavirus vectors
AU2004238843B2 (en) Insertion of furin protease cleavage sites in membrane proteins and uses thereof
JP2011504724A (ja) アルファウイルス粒子を生成する方法
JP2001519165A (ja) 細胞巨大分子合成の阻害が低減された組換えアルファウイルスベースのベクター
JP2010509222A5 (de)
US20200283497A1 (en) Rna replicon for expressing at cell receptor or an artificial t cell receptor
ES2503365T5 (es) Método para producir proteínas dependientes de vitamina K biológicamente activas por métodos recombinantes
US20080131933A1 (en) Process of Producing a Plastid-Targeted Protein in Plant Cells
Brinton et al. Simian hemorrhagic fever virus: Recent advances
WO2007122975A1 (ja) Ｈｇｆ前駆体蛋白質改変体及びその活性型蛋白質
ES2759916T3 (es) Vectores alfavirales y líneas celulares para la producción de proteínas recombinantes
Meas et al. Co-expression of self-cleaved multiple proteins derived from Porcine Reproductive and Respiratory Syndrome Virus by bi-cistronic and tri-cistronic DNA vaccines
CN101709305B (zh) 高分泌性三聚体蛋白的表达方法
Laguía Becher et al. Co-expressing Turnip Crinkle Virus-coat protein with the serine protease α-thrombin precursor (pFIIa) in Nicotiana benthamiana Domin
Galán et al. Differential role of N-terminal polyprotein processing in coronavirus genome replication and minigenome amplification